Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme

PURPOSE: To determine the safety and efficacy of hypofractionated intensity modulated radiation therapy (Hypo-IMRT) using helical tomotherapy (HT) with concurrent low dose temozolomide (TMZ) followed by adjuvant TMZ in patients with glioblastoma multiforme (GBM). METHODS AND MATERIALS: Adult patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Jastaniyah, Noha, Murtha, Albert, Pervez, Nadeem, Le, Duc, Roa, Wilson, Patel, Samir, Mackenzie, Marc, Fulton, Dorcas, Field, Colin, Ghosh, Sunita, Fallone, Gino, Abdulkarim, Bassam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599873/
https://www.ncbi.nlm.nih.gov/pubmed/23425509
http://dx.doi.org/10.1186/1748-717X-8-38

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599873/
https://www.ncbi.nlm.nih.gov/pubmed/23425509
http://dx.doi.org/10.1186/1748-717X-8-38

Ejemplares similares